Certain medications used to treat type II diabetes are raising concerns of a serious condition called ketoacidosis. Ketoacidosis occurs when the body produces high levels of blood acids called ketones. Ketoacidosis is a serious condition that can lead to a diabetic coma (passing out for a long time) that may result in hospitalization or even death.
The following medications are part of a class of drugs called sodium-glucose cotransporter-2 (SGLT2) inhibitors that are being investigated for potentially causing an increased risk of ketoacidosis, myocardial infarction (heart attacks), and kidney failure:
|Brand Name||Active Ingredients|
|Invokamet||Canagliflozin and Metformin|
|Xigduo XR||Dapagliflozin and Metformin extended-release|
|Glyxambi||Empagliflozin and Linagliptin|
Warning signs of ketoacidosis include the following symptoms:
- Difficulty breathing
- Abdominal pain
- Unusual fatigue or sleepiness
After receiving FDA approval in March 2013, reports of serious injuries from these medications started rolling in. The FDA Adverse Event Reporting System (FAERS) database contains 20 cases of acidosis reported as diabetic ketoacidosis in patients treated with SGLT2 inhibitors from March 2013 to June 2014.
A lawsuit filed against the manufacturer(s) of Invokana alleges the manufacturer(s) failed to warn patients and doctors of the increased risks of kidney failure, myocardial infarction (heart attacks) and other cardiovascular issues, and ketoacidosis.
As the information surrounding SGLT2 inhibitors continues to develop, patients taking these drugs should be vigilant for signs of this serious condition.
At Bachus & Schanker, LLC, Our Passion is Justice. We are Colorado's injury law firm and take great pride in our award-winning legal services. Serving our clients is our most important responsibility; and we are very proud of the results we have achieved on behalf of our clients. We understand and believe that the handling of every case is a partnership with our clients and therefore, at Bachus & Schanker we strive to ensure that our clients are fully informed. We want to make sure clients receive copies of significant letters, papers, and court pleadings in their case.
We will fight to achieve justice for you. If you or somebody you know took Invokana (Invokamet) or another SGLT2 inhibitor for type II diabetes and has experienced symptoms relating to ketoacidosis, kidney failure, or myocardial infarction (heart attacks), you should speak to an Attorney immediately for a free case consultation.
Speak to an Attorney today. Consultations for all fifty (50) states. Call us at 1.866.277.6711.